[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Gaia AG\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":65},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,40],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":10,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":34,"leadSponsor":36,"locationsCount":39},"100642915",false,"NCT07638657","Investigating Autimia, a Digital Intervention for Patients With Autism Spectrum Disorder","Investigating Autimia, a Digital Intervention for Patients With Autism Spectrum Disorder: Randomized Controlled Trial (Alnico Trial)","alnico","Inclusion Criteria:\n\n* prior suspected diagnosis of ASD by a healthcare professional\n* diagnosis of ASD (ICD-10 codes: F84.5, F84.0, F84.1) confirmed in a semi-structured diagnostic interview conducted as a telemedical consultation\n* IQ ≥ 80\n* increased levels of psychological distress (DASS-21 total score ≥ 21)\n* stable treatment (medication, psychotherapy, no treatment, …) for at least 30 days at the time of inclusion\n* sufficient knowledge of the German language\n* basic IT skills required for independent use of a digital intervention\n* consent to participation\n\nExclusion Criteria:\n\n* plans to change treatment (medication, psychotherapy, …) in the upcoming 3 months after inclusion\n* diagnosis of another severe psychiatric disorder (acute severe affective disorder, acute psychotic disorder, acute substance use disorder, borderline personality disorder, antisocial personality disorder)\n* acute suicidality\n* currently being under legal guardianship for healthcare decisions","ALL","18 Years","65 Years",{"count":20,"type":21},236,"ESTIMATED","INTERVENTIONAL",[24],"NA","The goal of this clinical trial is to find out if autimia, a digital health intervention, can help adults with ASD (Autism Spectrum Disorder) manage their daily lives and improve their well-being.\n\nThe main questions it aims to answer are:\n\n* Does autimia, together with regular treatment, improve health outcomes after three months better than regular treatment alone?\n* Are the positive effects of autimia still noticeable after six months?\n\nResearchers will compare two groups:\n\n* Intervention group: Participants use the autimia intervention and continue their usual treatment.\n* Control group: Participants continue with their usual treatment only.\n\nParticipants will:\n\n* Participate in a video call with a specialist to confirm a diagnosis of ASD\n* Fill out questionnaires online at the start of the study, after 3 months, and after 6 months\n* Continue with their usual treatment (both groups) and use autimia, a digital health intervention, for six months (intervention group only)",[27],"Autism Spectrum Disorder","RECRUITING","2026-06-12",{"date":31,"type":32},"2026-06-16","ACTUAL",{"date":29,"type":32},{"date":35,"type":21},"2027-06",{"name":37,"class":38},"Gaia AG","INDUSTRY",1,{"id":41,"slug":4,"hasResults":10,"nctId":42,"briefTitle":43,"officialTitle":44,"acronym":45,"eligibilityCriteria":46,"healthyVolunteers":10,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":47,"targetDuration":4,"studyType":22,"phases":49,"briefSummary":50,"conditions":51,"keywords":54,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":57,"lastUpdatePostDateStruct":58,"startDateStruct":60,"completionDateStruct":62,"leadSponsor":64,"locationsCount":39},"100515235","NCT05988866","Effects of a Digital Health Application (Lipodia) on LDL-cholesterol Levels","Effects of a Digital Health Application (Lipodia) on LDL-cholesterol Levels in Individuals With LDL-cholesterol Levels Above Recommended Targets for Reducing Cardiovascular Risk: Randomized Controlled Trial","DIGICHOL","Inclusion criteria\n\n* Age ≥ 18\n* Diagnosis of hypercholesterolemia (ICD-10 E78.0, E78.2, E78.4, E78.5, E78.8, E78.9) confirmed by a laboratory test and physician diagnosis\n* LDL-C levels above risk-adapted target\n* TG levels \\\u003C 400 mg\u002FdL\n* Stability of potential drug treatment during the last 4 weeks\n* Stability of potential hormonal treatment during the last 6 months\n* Patient was made aware of lifestyle measures by GP or specialist\n* Consent to participation\n* Sufficient knowledge of the German language\n\nExclusion criteria\n\n* Homozygous Familial Hypercholesterolemia (FH), given that it is a genetic condition which is relatively unresponsive to lifestyle changes\n* Hyperlipidemia type III, given that it is a genetic condition which is relatively unresponsive to lifestyle changes\n* Patients receiving plasmapheresis\n* Lp(a) \\> 50 mg\u002FdL\n* current pregnancy or planned pregnancy during the study period\n* planned major operations\n* liver dysfunction\n* end-stage renal failure\n* other systemic conditions that might interfere with successful study participation\n* Plans to change drug (including hormonal) treatment in the upcoming 6 months\n* Use of another digital intervention for hypercholesterolemia\u002Fdyslipidemia in the past",{"count":48,"type":21},272,[24],"The goal of this clinical trial is to find out if lipodia, a digital health intervention, can help lower cholesterol levels and improve other health measures in adults with high cholesterol.\n\nThe main questions it aims to answer are:\n\n* Does lipodia, together with regular treatment, lower LDL cholesterol (bad cholesterol) better than regular treatment alone?\n* Does lipodia help improve other health outcomes, like how confident participants feel in managing their health?\n\nResearchers will compare two groups:\n\n* Intervention group: Participants use the lipodia intervention and continue their usual treatment.\n* Control group: Participants continue with their usual treatment only.\n\nParticipants will:\n\n* Fill out questionnaires online and visit a certified lab at the start of the study, after 3 months, and after 6 months\n* Have blood tests at each lab visit to check their cholesterol and other blood fat levels\n* Continue with their usual treatment (both groups) and use lipodia, a digital health app, for six months (intervention group only)",[52,53],"Hypercholesterolemia","Dyslipidemias",[55,56],"LDL-C","digital intervention","2025-08-18",{"date":59,"type":32},"2025-08-22",{"date":61,"type":32},"2025-02-03",{"date":63,"type":21},"2026-01",{"name":37,"class":38},""]